Pulike Biological Engineering Inc
SSE:603566
Pulike Biological Engineering Inc
Total Liabilities
Pulike Biological Engineering Inc
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pulike Biological Engineering Inc
SSE:603566
|
Total Liabilities
¥477.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Total Liabilities
¥3B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Total Liabilities
¥4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
13%
|
CAGR 10-Years
19%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Total Liabilities
¥4.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
14%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Total Liabilities
¥1.9B
|
CAGR 3-Years
91%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Total Liabilities
¥1.3B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pulike Biological Engineering Inc
Glance View
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
See Also
What is Pulike Biological Engineering Inc's Total Liabilities?
Total Liabilities
477.3m
CNY
Based on the financial report for Sep 30, 2024, Pulike Biological Engineering Inc's Total Liabilities amounts to 477.3m CNY.
What is Pulike Biological Engineering Inc's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
19%
Over the last year, the Total Liabilities growth was -22%. The average annual Total Liabilities growth rates for Pulike Biological Engineering Inc have been 12% over the past three years , 19% over the past five years .
You don't have any saved screeners yet